5

PRIMARY DOCUMENT

Company: AXIM BIOTECHNOLOGIES, INC.
Filed: February 15, 2017
Period of Report: December 31, 2016
Accession Number: 0001078782-17-000217

View Document ↗ View on SEC.gov ↗